CBFB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.854200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.153800E-01
Normal-vs-Stage2
9.951200E-01
Normal-vs-Stage3
2.174600E-01
Normal-vs-Stage4
8.014300E-02
Stage1-vs-Stage2
4.090600E-01
Stage1-vs-Stage3
4.567200E-01
Stage1-vs-Stage4
9.544500E-03
Stage2-vs-Stage3
1.951190E-01
Stage2-vs-Stage4
4.302500E-02
Stage3-vs-Stage4
2.173900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.648400E-01
Normal-vs-AfricanAmerican
7.530400E-01
Normal-vs-Asian
4.712000E-01
Caucasian-vs-AfricanAmerican
5.515600E-01
Caucasian-vs-Asian
1.929400E-01
AfricanAmerican-vs-Asian
2.288800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.381400E-01
Normal-vs-Female
9.439800E-01
Male-vs-Female
5.721200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.808600E-01
Normal-vs-Age(41-60Yrs)
6.451200E-01
Normal-vs-Age(61-80Yrs)
8.334400E-01
Normal-vs-Age(81-100Yrs)
5.815200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.538600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.315200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.885400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.993960E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.393600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.844400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.030800E-01
Normal-vs-Daily Drinker
6.929200E-01
Normal-vs-Weekly Drinker
5.777000E-01
Normal-vs-Occasional Drinker
5.372800E-01
Normal-vs-Social Drinker
9.903600E-01
Non Drinker-vs-Daily Drinker
7.823600E-01
Non Drinker-vs-Weekly Drinker
7.392600E-01
Non Drinker-vs-Occasional Drinker
4.414000E-02
Non Drinker-vs-Social Drinker
5.483000E-01
Daily Drinker-vs-Weekly Drinker
9.669000E-01
Daily Drinker-vs-Occasional Drinker
6.933700E-02
Daily Drinker-vs-Social Drinker
4.985400E-01
Weekly Drinker-vs-Occasional Drinker
5.841600E-02
Weekly Drinker-vs-Social Drinker
4.657400E-01
Occasional Drinker-vs-Social Drinker
3.114000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.302600E-01
Normal-vs-Grade 2
5.206200E-02
Normal-vs-Grade 3
8.434000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.510400E-01
Grade 1-vs-Grade 3
1.413620E-01
Grade 1-vs-Grade 4
3.302600E-01
Grade 2-vs-Grade 3
5.404600E-01
Grade 2-vs-Grade 4
5.206200E-02
Grade 3-vs-Grade 4
8.434000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.555800E-01
Normal-vs-NonDiabetic
9.941800E-01
Diabetic-vs-NonDiabetic
1.460440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.657800E-01
Normal-vs-NoPancreatitis
9.624800E-01
Pancreatitis-vs-NoPancreatitis
6.640300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.828600E-01
Normal-vs-N1
9.645000E-01
N0-vs-N1
8.203400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.062350E-01
Normal-vs-TP53-NonMutant
2.974000E-01
TP53-Mutant-vs-TP53-NonMutant
7.721700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
